nafronyl has been researched along with Chronic Disease in 6 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trübestein, G | 1 |
| Böhme, H | 1 |
| Heidrich, H | 1 |
| Heinrich, F | 1 |
| Hirche, H | 1 |
| Maass, U | 1 |
| Mörl, H | 1 |
| Rudofsky, G | 1 |
| Williams, AJ | 1 |
| Osman, J | 1 |
| Skinner, C | 1 |
| Reiterer, W | 1 |
| Ratschow, R | 1 |
| Adhoute, G | 2 |
| Andreassian, B | 1 |
| Boccalon, H | 1 |
| Cloarec, M | 1 |
| Di Maria, G | 1 |
| Lefebvre, O | 1 |
| Mondine, P | 1 |
| Plagnol, P | 1 |
| Pointel, JP | 1 |
| Quancard, X | 1 |
| Bacourt, F | 1 |
| Barral, M | 1 |
| Cardon, JM | 1 |
| Chevalier, JM | 1 |
| Cuny, A | 1 |
| Gillet, M | 1 |
| Juhan, C | 1 |
| Leguay, G | 1 |
| Marion, J | 1 |
5 trials available for nafronyl and Chronic Disease
| Article | Year |
|---|---|
Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
Topics: Adult; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Pressure; Chronic Disease; Clinical T | 1984 |
Effects of naftidrofuryl on breathlessness and exercise tolerance in chronic bronchitis.
Topics: Aged; Bronchitis; Chronic Disease; Female; Furans; Humans; Lung; Male; Middle Aged; Nafronyl; Physic | 1982 |
[Effects of naftidrofuryl (Dusodril) on central hemodynamics and respiration].
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Furans; He | 1975 |
Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study.
Topics: Adult; Aged; Arteriosclerosis; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Huma | 1990 |
Naftidrofuryl in chronic arterial disease. Results of a six month controlled multicenter study using Naftidrofuryl tablets 200 mg.
Topics: Administration, Oral; Adult; Aged; Arteriosclerosis; Chronic Disease; Clinical Trials as Topic; Doub | 1986 |
1 other study available for nafronyl and Chronic Disease
| Article | Year |
|---|---|
[Conservative treatment of arterial occlusive diseases with naftidrofuryl hydrogen oxalate (author's transl)].
Topics: Adult; Aged; Arterial Occlusive Diseases; Chronic Disease; Diabetes Complications; Exercise Therapy; | 1976 |